Emergent_CDMO_Bulk_Drug_Manufacturing_color

Our Sites

 

Gaithersburg

300 Professional Drive

Gaithersburg, MD 20879 USA

Tel: +1 240-631-3200


Our Gaithersburg, Maryland facility is a 348,000 sq.ft. two story building containing non-cGMP laboratories and office space for Emergent's Development Services team and associated groups. 

Capabilities:  
  • Process Development
  • Analytical Development
  • Lab-scale Manufacturing

Technologies:

  • Mammalian
  • Microbial
  • Viral
  • Advanced Therapies
Gaithersburg
 

Baltimore, MD (Bayview)

5901 East Lombard Street
Baltimore, MD 21224

Tel: +1 410-246-6200

The Baltimore Bayview facility, located on 7 acres of land at 5901 East Lombard Street, Baltimore, Maryland, offers flexible drug substance manufacturing in its 112,000 sq. ft. facility with four independent manufacturing areas up to 4,000 L scale that employ single-use manufacturing technology, testing laboratories and office space.  It is also home to our Center for Innovation in Advanced Development and Manufacturing (CIADM).

Capabilities:  

  • Drug Substance 

Technologies:

  • Mammalian
  • Microbial
  • Viral
Bayview-exterior
 

Lansing

3500 N. Martin Luther King Jr. Blvd.
Lansing, MI 48906

Tel: +1 517-327-8000


The Lansing, Michigan facility specializes in high containment and high-risk manufacturing. This site makes microbial products for both government agencies and commercial pharmaceutical companies. 

Capabilities:  

  • Drug Substance

Technologies:

  • Microbial

 

EBSI_Lansing
 

Canton

50 Shawmut Road
Canton, MA 02021
Tel: +1 781-302-3000

The Canton facility is located approximately 25 miles from the center of Boston and provides viral drug substance manufacturing for clinical and commercial supply.

Capabilities:  

  • Drug Substance

Technologies:

  • Viral
  • Advanced therapies 

EBSI-Canton_web
 

Bern

Oberriedstrasse 68
CH-3174 Thörishaus Switzerland
Tel: +41 31 888 51 11

Our Bern, Switzerland facility hosts expertise in mammalian, microbial and viral drug substance and drug product, including oral vaccines used to treat infectious diseases. This site serves as our European-based cGMP manufacturing footprint with R&D capabilities for novel specialty vaccines and synergies with our US sites.

Capabilities: 

  • Drug Substance

Technologies:

  • Mammalian
  • Microbial
  • Viral
EBSI-Berna
 

BALTIMORE, MD (CAMDEN)

1111 S. Paca Street
Baltimore, MD 21230
Tel: +1 410-843-5000

Emergent’s Baltimore Camden facility hosts drug product manufacturing for sterile injectables. At this facility we perform pharmaceutical product development and filling services for injectable and other sterile products, as well as, process design, technical transfer, manufacturing validations, laboratory support, aseptic filling, lyophilization, final packaging and accelerated and ongoing stability studies.

Capabilities: 

  • Drug Product 

Technologies: 

  • Small Molecule
  • Mammalian
  • Microbial

 

EBSI_Baltimore
 

Rockville

9920 Medical Center Drive
Rockville, MD 20850
Tel: +1 240-453-2200

The Rockville facility located just 10 minutes from Emergent headquarters in Gaithersburg, MD, was built in 1999 and consists of over 70,000 sq. ft. This site accommodates drug product manufacturing for viral vaccines and can fill, freeze dry, inspect, label, package and store viral vaccine products.

Capabilities:

  • Drug product

Technologies:

  • Viral 

EBSI Rockville- Web
 

Hattiesburg

46 Shelby Thames Drive
Hattiesburg, MS 39402
Tel: +1 517-327-8000

Emergent's Hattiesburg, MS site is located approximately 100 miles outside of New Orleans, LA and houses a modern packaging operation.

Capabilities:

  • Drug Product

Technologies: 

  • Packaging

HATTIESBURG
 

Winnipeg

155 Innovation Drive
Winnipeg, MB, CA
R3T 5Y3
Tel: +1 204-275-4200

This 160,000 sq. ft. facility is licensed for development services, cGMP drug substance and drug product / packaging. This site is the home to our plasma hyper-immune platform to provide clinical and commercial supply using human and equine plasma.

Capabilities: 

  • Drug Substance
  • Drug Product
  • Development Services

Technologies:

  • Plasma
EBSI_ Winnipeg

Interested in Starting a Project?

If you are interested in potentially starting a project with Emergent, want to find out more information about Emergent, or would like to have us contact you for any reason, please use this web form to send us information or questions, or call us toll-free at 1-800-441-4225